Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice history

Ocular Therapeutix Inc News

Ocular Therapeutix Stock Slumps; Dry-Eye Drug Misses Trial Endpoint HOLD

Ocular Therapeutix shares lost a third of their market value after the biopharma's candidate for dry-eye disease missed its key endpoint.

5 Top Stock Gainers for Monday: Aspen, SoFi, Flexion Therapeutics

Aspen Technology, Sofi Technologies, Flexion Therapeutics, Adamas Pharmaceuticals and Ocular Therapeutix are five top stock gainers for Monday.

Why Market Action is Making This Columnist Wary

The recent trading environment reminds Real Money's 'Rev Shark' of what was going on in February.

Elanco Animal Health, 3D Systems: 5 Stock Gainers for Wednesday

Elanco Animal Health, Ocular Therapeutix, 3D Systems, Perion Networks and Quanterix are five of Wednesday's top stock gainers.

Biotech Movers: Ocular, Alder, Flexion

Ocular Therapeutix, Alder BioPharmaceuticals, Flexion Therapeutics were among the biotech stock movers in premarket trading on July 12.

Breaking News

The Good Times Are Over for Startups

Sequoia Capital and Y Combinator have told startups that cutting costs is a priority.

Elon Musk Throws Dogecoin a Lifeline

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

Disney Fans Angry, Excited About New Guardians of the Galaxy Ride

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora Cannabis Slashing Weed Capacity in Profitability Push

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.